Danubia J. Hester

Danubia Hester practices at Maryland Oncology Hematology, P.A. in Norfolk, Virginia.

Danubia Hester's NPI, 1326426057, was assigned on May 14, 2015. Danubia Hester graduated from Howard University College of Medicine in 2015. Danubia Hester holds Maryland license D95076.

Danubia Hester's primary practice is Maryland Oncology Hematology, P.A., at 6350 Center Dr, Norfolk, VA 23502 in Norfolk City. The practice phone is (301) 812-3900.

Danubia Hester's primary practice is Maryland Oncology Hematology, P.A. in Norfolk, Virginia. Danubia Hester is also affiliated with University of Maryland Capital Region Medical Center. The medical group on file is Inova Urgent Care Center. Dmand AI also links Danubia Hester to 2 more hospitals, 1 group practice or clinic, 1 home health agency and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Danubia Hester practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Danubia Hester's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Danubia Hester is licensed in Maryland.

CMS data shows 65,432 Medicare services from Danubia Hester across 55 procedure codes in 2024, for 622 Medicare patients. Medicare paid $696,025 for them.

CMS counts 622 Medicare patients who saw Danubia Hester in 2024. The largest group is 75 to 84, with 266 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.08, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Danubia Hester's median patient age at 61, with 69% women.

In 2024, Danubia Hester wrote 424 Medicare Part D claims for 69 patients. 75% of them were for generic drugs. CMS names the drug for 231 of them, across 11 drugs with 11 or more claims each, at $654,159 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Danubia Hester for performance year 2024, reported as part of a group. Danubia Hester accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Danubia Hester as offering telehealth.

CMS Open Payments shows 429 general payments to Danubia Hester from 73 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 93% of the total. Janssen Pharmaceuticals, Inc paid the most, $787.

Danubia Hester graduated from Howard University College of Medicine in 2015.